Journal of Attention Disorders

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Free Access - Register Here

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
1087054707308490v1
11/6/720    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adler, L. A.
Right arrow Articles by Biederman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adler, L. A.
Right arrow Articles by Biederman, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
First published on October 29, 2007, doi:10.1177/1087054707308490

Journal of Attention Disorders 2008;11:720.

A more recent version of this article appeared on May 1, 2008

Article

Functional Outcomes in the Treatment of Adults With ADHD

Lenard A. Adler, M.D.1*, Thomas J. Spencer, M.D.2, Louise R. Levine, M.D.3, Janet L. Ramsey, M.S., M.P.H.3, Roy Tamura, Ph.D.3, Douglas Kelsey, M.D., Ph.D.3, Susan G. Ball, Ph.D.3, Albert J. Allen, M.D., Ph.D.3, and Joseph Biederman, M.D.2

1 New York University School of Medicine
2 Massachusetts General Hospital and Harvard Medical School
3 Lilly Research Laboratories

* To whom correspondence should be addressed. E-mail: Lenard.adler{at}med.nyu.edu.


  Abstract
Objective: ADHD is associated with significant functional impairment in adults. The present study examined functional outcomes following 6-month double-blind treatment with either atomoxetine or placebo. Method: Patients were 410 adults (58.5% male) with DSM-IV –defined ADHD. They were randomly assigned to receive either atomoxetine 40 mg/day to 80 mg/day (n =271) or placebo (n =139). The primary functional outcome measure was the Endicott Work Productivity Scale (EWPS), and the secondary measure was the Adult ADHD Quality of Life (AAQoL). Patients were seen for four visits in 6 months. Results: At 6 months, both groups had nonsignificantly different improvements in EWPS total scores. Atomoxetine-treated patients showed significantly greater improvement than placebo-treated patients on the AAQoL after controlling for baseline severity of ADHD. Both treatment groups had low 6-month study completion rates. Conclusion: Following 6-month treatment with atomoxetine, adults with ADHD showed significantly greater improvement in functioning on disease-specific measures of quality of life than patients treated with placebo. (J. of Att. Dis. XXXX; XX(X) xx-xx)
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?